Their use for Alcohol Use Disorder (AUD) or drug addiction is considered "off-label." However, groundbreaking clinical research from 2025 and 2026 demonstrates that these medications significantly dampen the brain's reward centers, drastically curbing cravings for alcohol, opioids, and nicotine
Intracellularly, CHAC1 enzymatically degrades GSH into 5-oxoproline and Cys-Gly, acting as a pro-ferroptotic execution signal by accelerating GSH exhaustion 151
We hope that this tool helps patients with the information they need to start their health journey with GLP-1s
If you would like to use the telemedicine option, please use the links below or contact us
Psoriasis: a STAT3-Centric view
NAD can improve cognition functions and boost your mood